Examining fatigue in COPD: development, validity and reliability of a modified version of FACIT-F scale

Khaled Al-shair, Hana Muellerova, Janelle Yorke, Stephen I Rennard, Emiel F M Wouters, Nicola A Hanania, Amir Sharafkhaneh, Jørgen Vestbo, ECLIPSE investigators, Khaled Al-shair, Hana Muellerova, Janelle Yorke, Stephen I Rennard, Emiel F M Wouters, Nicola A Hanania, Amir Sharafkhaneh, Jørgen Vestbo, ECLIPSE investigators

Abstract

Introduction: Fatigue is a disruptive symptom that inhibits normal functional performance of COPD patients in daily activities. The availability of a short, simple, reliable and valid scale would improve assessment of the characteristics and influence of fatigue in COPD.

Methods: At baseline, 2107 COPD patients from the ECLIPSE cohort completed the Functional Assessment of Chronic Illness Therapy Fatigue (FACIT-F) scale. We used well-structured classic method, the principal components analysis (PCA) and Rasch analysis for structurally examining the 13-item FACIT-F.

Results: Four items were less able to capture fatigue characteristics in COPD and were deleted. PCA was applied to the remaining 9 items of the modified FACIT-F and resulted in three interpretable dimensions: i) general (5 items); ii) functional ability (2 items); and iii) psychosocial fatigue (2 items). The modified FACIT-F had high internal consistency (Cronbach's α = 0.91) and it did not fit a uni-dimensional Rasch model, confirming the prior output from the PCA. The correlations between total score and each dimension were ≥ 0.64 and within dimensions ≥0.43 (p < 0.001 for all).The original and modified FACIT-F had significant convergent validity; its scores were associated with SGRQ total score (0.69 and 0.7) and mMRC dyspnoea scores (0.48 and 0.47), (p = <0.001 for all). The scale had meaningful discriminating ability in identifying patients with poor exercise performance and more depressive symptoms.

Conclusion: The original and modified FACIT-F are valid and reliable scales in COPD. The modified version is shorter and measures not only total fatigue but also its sub-components in COPD.

Trial registration: ClinicalTrials.gov NCT00292552.

Figures

Figure 1
Figure 1
Flow chart illustrating the development of the COPD modified FACT-F scale.

References

    1. Theander K, Unosson M. Fatigue in patients with chronic obstructive pulmonary disease. J Adv Nurs. 2004;45(2):172–177. doi: 10.1046/j.1365-2648.2003.02878.x.
    1. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987;42:773–778. doi: 10.1136/thx.42.10.773.
    1. Man WD, Soliman MG, Gearing J, Radford SG, Rafferty GF, Gray BJ, Polkey MI, Moxham J. Symptoms and quadriceps fatigability after walking and cycling in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003;168(5):562–567. doi: 10.1164/rccm.200302-162OC.
    1. Kapella MC, Larson JL, Patel MK, Covey MK, Berry JK. Subjective fatigue, influencing variables, and consequences in chronic obstructive pulmonary disease. Nurs Res. 2006;55:10–17. doi: 10.1097/00006199-200601000-00002.
    1. Baghai-Ravary R, Quint JK, Goldring JJ, Hurst JR, Donaldson GC, Wedzicha JA. Determinants and impact of fatigue in patients with chronic obstructive pulmonary disease. Respir Med. 2009;103:216–223. doi: 10.1016/j.rmed.2008.09.022.
    1. Baltzan MA, Scott AS, Wolkove N, Bailes S, Bernard S, Bourbeau J, Maltais F. Canadian COPD Pulmonary Rehabilitation Research Group. Fatigue in COPD: Prevalence and effect on outcomes in pulmonary rehabilitation. Chron Respir Dis. 2011;8(2):119–128.
    1. Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage. 1997;13:63–74.
    1. Cella D, Lai JS, Chang CH, Peterman A, Slavin M. Fatigue in cancer patients compared with fatigue in the general United States population. Cancer. 2002;94:528–538. doi: 10.1002/cncr.10245.
    1. Vestbo J, Anderson W, Coxson HO, Crim C, Dawber F, Edwards L, Hagan G, Knobil K, Lomas DA, MacNee W, Silverman EK, Tal-Singer R. ECLIPSE Investigators. Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE) Eur Respir J. 2008;31(4):869–873. doi: 10.1183/09031936.00111707.
    1. Agusti A, Calverley PM, Celli B, Coxson HO, Edwards LD, Lomas DA, MacNee W, Miller BE, Rennard S, Silverman EK, Tal-Singer R, Wouters E, Yates JC, Vestbo J. ECLIPSE Investigators. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res. 2010;11:122.
    1. Meguro M, Barley EA, Spencer S, Jones PW. Development and Validation of an Improved. COPD-Specific Version of the St. George Respiratory Questionnaire. Chest. 2007;132(2):456–463. doi: 10.1378/chest.06-0702.
    1. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–586. doi: 10.1136/thx.54.7.581.
    1. Radloff LS. The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Measur. 1977;1:385–401. doi: 10.1177/014662167700100306.
    1. American Thoracic Society. ATS Statement: Guidelines for the Six-Minute Walk Test. Am J Respir Crit Care Med. 2002;166:111–117.
    1. O'Leary CJ, Jones PW. The influence of decisions made by developers on health status questionnaire content. Qual Life Res. 1998;7(6):545–550.
    1. Al-shair K, Kolsum U, Berry P, Smith J, Caress A, Singh D, Vestbo J. Development, dimensions, reliability and validity of the novel Manchester COPD fatigue scale. Thorax. 2009;64(11):950–955. doi: 10.1136/thx.2009.118109.
    1. Wiklund IK, Fullerton S, Hawkey CJ, Jones RH, Longstreth GF, Mayer EA, Peacock RA, Wilson IK, Naesdal J. An irritable bowel syndrome-specific symptom questionnaire: development and validation. Scand J Gastroenterol. 2003;38(9):947–954. doi: 10.1080/00365520310004209.
    1. Tabachnick B, Fidell L. Using Multivariate Statistics. Boston: Allyn and Bacon; 2007. pp. 607–675.
    1. Rasch B. Probabilistic models for some intelligence and attainment tests. Copenhagen, Denmark: Danmarks Paedogogiske Institut; 1960.
    1. Yorke J, Jones PW, Swigris JJ. Development and validity testing of an IPF-specific version of the St George's Respiratory Questionnaire. Thorax. 2011;65(10):921–926.
    1. Pallant JF, Tennant A. An introduction to the Rasch measurement model: an example using the Hospital Anxiety and Depression Scale (HADS) Br J Clin Psychol. 2007;46(Pt 1):1–18.
    1. Conaghan PG, Emerton M, Tennant A. Internal construct validity of the Oxford Knee Scale: evidence from Rasch measurement. Arthritis Rheum. 2007;57(8):1363–1367. doi: 10.1002/art.23091.
    1. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrica. 1951;16:297–334. doi: 10.1007/BF02310555.
    1. Pallant J. SPSS survival manual. Checking the reliability of a scale. Third. McGraw-Hill: Open University Press; 2007.
    1. Cote CG, Casanova C, Marín JM, Lopez MV, Pinto-Plata V, de Oca MM, Dordelly LJ, Nekach H, Celli BR. Validation and comparison of reference equations for the 6-min walk distance test. Eur Respir J. 2008;31(3):571–578. doi: 10.1183/09031936.00104507.
    1. Butt Z, Wagner LI, Beaumont JL, Paice JA, Peterman AH, Shevrin D, Von Roenn JH, Carro G, Straus JL, Muir JC, Cella D. Use of a single-item screening tool to detect clinically significant fatigue, pain, distress, and anorexia in ambulatory cancer practice. J Pain Symptom Manage. 2008;35(1):20–30. doi: 10.1016/j.jpainsymman.2007.02.040.
    1. Ream E, Richardson A. Fatigue: a concept analysis. Int J Nurs Stud. 1996;33(5):519–529. doi: 10.1016/0020-7489(96)00004-1.
    1. Scharf SM, Maimon N, Simon-Tuval T, Bernhard-Scharf BJ, Reuveni H, Tarasiuk A. Sleep quality predicts quality of life in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2011;6:1–12.
    1. Piper B, Carrieri-Kohlman V, Lindsey A, West C. Fatigue. Pathophysiological phenomena in nursing: Human responses to illness. 2. Philadelphia, PA: W.B Saunders Company; 1993.
    1. Al-shair K, Kolsum U, Dockry R, Morris J, Singh D, Vestbo J. Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD. Respir Res. 2011;12:3. doi: 10.1186/1465-9921-12-3.
    1. Smets EM, Garssen B, Bonke B, De Haes JC. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995;39(3):315–325. doi: 10.1016/0022-3999(94)00125-O.
    1. Piper B, Lindsey A, Dodd M, The development of an instrument to measure the subjective dimension of fatigue. Key aspects of comfort: Management of pain, fatigue and nausea. New York: Springer; 1989. pp. 199–208.
    1. Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis. 1994;18(Suppl 1):S79–S83.
    1. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648–654. doi: 10.1183/09031936.00102509.
    1. Jones PW, Brusselle G, Dal Negro RW, Ferrer M, Kardos P, Levy ML, Perez T, Soler Cataluña JJ, van der Molen T, Adamek L, Banik N. Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J. 2011;38(1):29–35. doi: 10.1183/09031936.00177210.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit